Bioadaptives, Inc. (BDPT) Gross Margin (2016 - 2026)

Bioadaptives (BDPT) posted Gross Margin of 74.59% for Q1 2026, up 2.57% sequentially from 72.72% in Q4 2025.

Bioadaptives, Inc. (BDPT) Gross Margin (2016 - 2026) Analysis & Trends

Bioadaptives has reported Gross Margin for 9 years, with the latest figure at 74.59% in Q1 2026.

Quarterly Gross Margin changed N/A year-over-year to 74.59% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 69.81% (up 626.0% YoY) and the FY2025 annual result came in at 68.37%, up 3656.0% from the prior year.
Gross Margin improved to 74.59% in Q1 2026 per BDPT's latest filing, from 72.72% in the prior quarter.
Over five years, Gross Margin peaked at 83.14% in Q3 2025 and troughed at 25.85% in Q4 2022.
A 5-year average of 51.24% and a median of 54.23% in 2023 frame the typical range for Gross Margin.
The sharpest annual moves came in 2023 and 2025: Gross Margin surged 2353 bps in 2023, then sank 3053 bps in 2025.
Over 5 years, Gross Margin stood at 25.85% in 2022, then jumped by 45 bps to 37.48% in 2023, then soared by 70 bps to 63.56% in 2024, then increased by 14 bps to 72.72% in 2025, then advanced by 3 bps to 74.59% in 2026.
According to Business Quant data, Gross Margin over the past three periods registered 74.59%, 72.72%, and 83.14% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Download Data